Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Neumora Therapeutics, Inc. Common Stock

NMRA Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of NMRA by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
NMRA Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
NMRA Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
NMRA Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in NMRA holdings by institutional investors

Quarterly net insider trading by NMRA's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for NMRA

Quiver Logo

No former government officials on record as having lobbied for NMRA

Revolving Door Dashboard

NMRA Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

NMRA Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
NMRA Income Statement
NMRA Balance Sheet
NMRA Cash Flow
U.S. Patents

New NMRA patent grants

  • Patent Title: Predicting the outcome of a clinical trial using a machine learning model Sep. 08, 2026
  • Patent Title: Methods of treating neurological disorders Jul. 29, 2025
  • Patent Title: 1-(2,6-diazaspiro[3.3]heptan-6-yl)-5,6-dihydro-4h-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine derivatives and related compounds as vasopressin antagonists for the treatment of neuro-psychological disorders Mar. 11, 2025
  • Patent Title: System and method of facial analysis Feb. 25, 2025
  • Patent Title: Crystalline salt forms of kappa opioid receptor antagonist and products and methods related thereto Dec. 24, 2024
  • Patent Title: Vasopressin receptor antagonists and products and methods related thereto Nov. 26, 2024
  • Patent Title: Multimodal dynamic attention fusion Sep. 10, 2024
  • Patent Title: Machine learning-based diagnostic classifier Jun. 04, 2024
  • Patent Title: Methods of treating neurological disorders May. 28, 2024
  • Patent Title: System and method for identifying transdiagnostic features shared across mental health disorders Mar. 26, 2024
  • Patent Title: Estimating uncertainty in predictions generated by machine learning models Jan. 30, 2024
  • Patent Title: Vasopressin receptor antagonists and products and methods related thereto Jan. 02, 2024
  • Patent Title: Systems and methods for screening, diagnosing, and stratifying patients Jan. 02, 2024
  • Patent Title: Methods and tools for detecting, diagnosing, predicting, prognosticating, or treating a neurobehavioral phenotype in a subject Dec. 12, 2023
  • Patent Title: Machine learning systems for training encoder and decoder neural networks Oct. 24, 2023
  • Patent Title: Methods and systems for computer-generated predictive application of neuroimaging and gene expression mapping data Oct. 17, 2023
  • Patent Title: Machine learning systems for generating multi-modal data archetypes Aug. 29, 2023
  • Patent Title: Machine learning-based diagnostic classifier Aug. 01, 2023
  • Patent Title: Machine learning-based diagnostic classifier Jun. 13, 2023
  • Patent Title: Machine learning systems for processing multi-modal patient data Jun. 06, 2023
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to NMRA from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
NMRA News

Recent insights relating to NMRA

CNBC Recommendations

Recent picks made for NMRA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NMRA

NMRA Analyst Ratings

NMRA Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
NMRA Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $NMRA stock a Buy, Sell, or Hold?

  • What is the price target for $NMRA stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

NMRA Top Shareholders
Shareholder
Shares Held
NMRA Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $NMRA stock?

  • Who owns the most shares of $NMRA stock?

  • What funds own $NMRA stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

NMRA Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view NMRA Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About NMRA

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

  • Address Watertown, MA
  • Market Cap 137.4 million
  • Employees 63
  • Industrial Classification Biological Products, (No Diagnostic Substances)

Neumora Therapeutics, Inc. Common Stock (NMRA) Historical Stock Prices

Neumora Therapeutics, Inc. Common Stock (NMRA) closed at $0.7313 on September 23, 2026. Over the past year its adjusted close ranged from $0.6918 to $3.59. Daily prices go back to September 15, 2023, 758 trading days in all.

  • 1 month-52.05%
  • 3 months-49.91%
  • Year to date-59.15%
  • 1 year-61.71%
  • 3 years-93.37%
  • 5 years—
  • Max-95.50%
See every congressional and insider trade on the NMRA price chart

Quiver Premium charts NMRA's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 0.7677 0.7785 0.6903 0.7313 0.7313 1,692,159
Sep 22, 2026 0.6961 0.8111 0.6900 0.7785 0.7785 3,211,891
Sep 21, 2026 0.7371 0.7700 0.6805 0.6918 0.6918 1,675,812
Sep 18, 2026 0.7410 0.7642 0.7100 0.7300 0.7300 3,882,674
Sep 17, 2026 0.7800 0.8082 0.7316 0.7500 0.7500 3,424,720
Sep 16, 2026 0.8442 0.8921 0.7600 0.7732 0.7732 3,215,468
Sep 15, 2026 1.02 1.03 0.8300 0.8313 0.8313 1,420,267
Sep 14, 2026 1.03 1.06 0.9900 0.9994 0.9994 555,258
Sep 11, 2026 1.16 1.16 1.02 1.04 1.04 1,880,837
Sep 10, 2026 1.20 1.21 1.11 1.14 1.14 600,847
Sep 9, 2026 1.26 1.26 1.19 1.20 1.20 586,948
Sep 8, 2026 1.29 1.34 1.24 1.25 1.25 757,238
Sep 4, 2026 1.35 1.36 1.29 1.31 1.31 549,208
Sep 3, 2026 1.39 1.39 1.34 1.35 1.35 386,040
Sep 2, 2026 1.35 1.41 1.34 1.38 1.38 532,233
Sep 1, 2026 1.33 1.36 1.31 1.33 1.33 532,616
Aug 31, 2026 1.40 1.45 1.32 1.33 1.33 633,099
Aug 28, 2026 1.50 1.51 1.38 1.39 1.39 696,285
Aug 27, 2026 1.55 1.57 1.48 1.48 1.48 534,039
Aug 26, 2026 1.50 1.57 1.46 1.56 1.56 536,190
Aug 25, 2026 1.53 1.57 1.48 1.50 1.50 475,567
Aug 24, 2026 1.58 1.65 1.51 1.52 1.52 1,155,384
Aug 21, 2026 1.51 1.64 1.51 1.63 1.63 499,105
Aug 20, 2026 1.61 1.63 1.48 1.51 1.51 1,485,618
Aug 19, 2026 1.65 1.71 1.61 1.64 1.64 716,166
Aug 18, 2026 1.50 1.65 1.48 1.64 1.64 781,774
Aug 17, 2026 1.55 1.58 1.46 1.52 1.52 1,352,838
Aug 14, 2026 1.69 1.71 1.58 1.60 1.60 1,165,565
Aug 13, 2026 1.71 1.78 1.68 1.73 1.73 488,292
Aug 12, 2026 1.70 1.76 1.68 1.71 1.71 351,605
Aug 11, 2026 1.62 1.70 1.61 1.70 1.70 517,500
Aug 10, 2026 1.65 1.66 1.57 1.62 1.62 580,793
Aug 7, 2026 1.64 1.68 1.62 1.63 1.63 687,348
Aug 6, 2026 1.61 1.67 1.60 1.64 1.64 345,694
Aug 5, 2026 1.58 1.66 1.54 1.61 1.61 656,003
Aug 4, 2026 1.64 1.69 1.58 1.60 1.60 830,971
Aug 3, 2026 1.62 1.69 1.61 1.64 1.64 392,481
Jul 31, 2026 1.56 1.61 1.48 1.61 1.61 1,628,077
Jul 30, 2026 1.65 1.69 1.62 1.65 1.65 511,344
Jul 29, 2026 1.69 1.70 1.62 1.65 1.65 666,818
Jul 28, 2026 1.65 1.68 1.61 1.68 1.68 676,957
Jul 27, 2026 1.51 1.71 1.50 1.66 1.66 811,306
Jul 24, 2026 1.54 1.54 1.46 1.49 1.49 665,735
Jul 23, 2026 1.51 1.56 1.49 1.56 1.56 414,728
Jul 22, 2026 1.59 1.61 1.51 1.54 1.54 468,332
Jul 21, 2026 1.62 1.67 1.59 1.61 1.61 408,154
Jul 20, 2026 1.60 1.67 1.60 1.63 1.63 486,384
Jul 17, 2026 1.60 1.72 1.59 1.61 1.61 1,049,602
Jul 16, 2026 1.62 1.64 1.59 1.60 1.60 632,040
Jul 15, 2026 1.58 1.66 1.58 1.63 1.63 455,547
Jul 14, 2026 1.59 1.63 1.57 1.58 1.58 771,862
Jul 13, 2026 1.66 1.66 1.55 1.60 1.60 890,702
Jul 10, 2026 1.64 1.71 1.57 1.68 1.68 1,024,411
Jul 9, 2026 1.62 1.67 1.57 1.65 1.65 981,972
Jul 8, 2026 1.70 1.80 1.59 1.59 1.59 2,157,732
Jul 7, 2026 1.67 1.84 1.64 1.73 1.73 1,392,308
Jul 6, 2026 1.65 1.75 1.65 1.69 1.69 732,200
Jul 2, 2026 1.62 1.73 1.61 1.67 1.67 1,058,036
Jul 1, 2026 1.71 1.71 1.56 1.62 1.62 960,690
Jun 30, 2026 1.71 1.81 1.65 1.70 1.70 1,299,910
Jun 29, 2026 1.60 1.73 1.60 1.72 1.72 1,656,291
Jun 26, 2026 1.50 1.66 1.48 1.64 1.64 14,976,488
Jun 25, 2026 1.45 1.53 1.40 1.51 1.51 923,939
Jun 24, 2026 1.60 1.60 1.40 1.46 1.46 2,212,355
Jun 23, 2026 1.49 1.65 1.49 1.61 1.61 2,048,895
Jun 22, 2026 1.41 1.56 1.41 1.53 1.53 1,529,644
Jun 18, 2026 1.58 1.63 1.43 1.51 1.51 2,200,626
Jun 17, 2026 1.46 1.54 1.32 1.53 1.53 5,352,195
Jun 16, 2026 0.9500 1.59 0.9200 1.56 1.56 28,535,158
Jun 15, 2026 0.9302 1.12 0.8302 0.9145 0.9145 17,741,653
Jun 12, 2026 1.78 1.84 1.76 1.78 1.78 719,390
Jun 11, 2026 1.65 1.84 1.63 1.78 1.78 1,148,322
Jun 10, 2026 1.63 1.67 1.57 1.60 1.60 671,390
Jun 9, 2026 1.63 1.70 1.60 1.65 1.65 785,186
Jun 8, 2026 1.68 1.71 1.60 1.62 1.62 600,977
Jun 5, 2026 1.75 1.75 1.61 1.63 1.63 864,601
Jun 4, 2026 1.75 1.78 1.73 1.75 1.75 704,179
Jun 3, 2026 1.75 1.76 1.70 1.74 1.74 647,465
Jun 2, 2026 1.83 1.83 1.73 1.75 1.75 840,490
Jun 1, 2026 1.85 1.89 1.78 1.82 1.82 803,429
May 29, 2026 1.89 1.96 1.85 1.85 1.85 892,391
May 28, 2026 1.84 1.93 1.82 1.88 1.88 1,285,261
May 27, 2026 1.83 1.91 1.80 1.86 1.86 719,893
May 26, 2026 1.91 1.93 1.80 1.84 1.84 1,292,978
May 22, 2026 1.86 1.98 1.82 1.85 1.85 1,362,275
May 21, 2026 1.71 1.90 1.66 1.85 1.85 1,593,813
May 20, 2026 1.70 1.78 1.68 1.72 1.72 1,074,445
May 19, 2026 1.76 1.79 1.67 1.67 1.67 1,018,280
May 18, 2026 1.84 1.87 1.73 1.77 1.77 839,479
May 15, 2026 1.94 1.96 1.83 1.84 1.84 829,240
May 14, 2026 1.79 1.99 1.76 1.97 1.97 1,375,809
May 13, 2026 1.90 1.90 1.75 1.78 1.78 1,794,270
May 12, 2026 1.87 1.95 1.83 1.90 1.90 821,918
May 11, 2026 1.85 1.89 1.74 1.87 1.87 1,465,247
May 8, 2026 1.97 1.98 1.75 1.83 1.83 2,129,663
May 7, 2026 2.33 2.37 1.90 1.94 1.94 2,768,617
May 6, 2026 2.32 2.42 2.27 2.33 2.33 1,708,833
May 5, 2026 2.36 2.40 2.23 2.30 2.30 701,455
May 4, 2026 2.44 2.48 2.29 2.31 2.31 1,236,989
May 1, 2026 2.47 2.55 2.33 2.44 2.44 3,502,546
Apr 30, 2026 2.29 2.51 2.23 2.47 2.47 1,227,629
Apr 29, 2026 2.24 2.37 2.20 2.25 2.25 1,144,143
Apr 28, 2026 2.22 2.30 2.16 2.25 2.25 2,071,710
Apr 27, 2026 2.25 2.31 2.18 2.22 2.22 953,048
Apr 24, 2026 2.23 2.26 2.15 2.25 2.25 854,707
Apr 23, 2026 2.30 2.31 2.19 2.23 2.23 1,186,874
Apr 22, 2026 2.42 2.46 2.26 2.31 2.31 1,566,860
Apr 21, 2026 2.20 2.41 2.09 2.32 2.32 1,887,593
Apr 20, 2026 2.12 2.32 2.07 2.19 2.19 1,962,677
Apr 17, 2026 2.04 2.19 1.99 2.15 2.15 1,419,777
Apr 16, 2026 2.07 2.07 1.96 2.00 2.00 684,679
Apr 15, 2026 2.03 2.10 1.98 2.06 2.06 1,103,232
Apr 14, 2026 2.10 2.17 1.99 2.03 2.03 2,097,773
Apr 13, 2026 2.03 2.21 2.02 2.06 2.06 924,755
Apr 10, 2026 2.09 2.14 2.00 2.04 2.04 765,836
Apr 9, 2026 2.16 2.16 2.05 2.08 2.08 849,581
Apr 8, 2026 2.22 2.24 2.15 2.18 2.18 1,280,409
Apr 7, 2026 2.11 2.19 2.04 2.13 2.13 1,302,169
Apr 6, 2026 2.01 2.15 1.97 2.12 2.12 1,706,597
Apr 2, 2026 2.06 2.10 1.98 2.00 2.00 1,238,189
Apr 1, 2026 2.00 2.10 1.97 2.09 2.09 1,622,608
Mar 31, 2026 1.91 2.04 1.89 1.95 1.95 3,155,768
Mar 30, 2026 2.15 2.15 1.82 1.93 1.93 2,792,650
Mar 27, 2026 2.49 2.49 2.28 2.33 2.33 954,525
Mar 26, 2026 2.49 2.61 2.45 2.49 2.49 1,115,048
Mar 25, 2026 2.50 2.62 2.46 2.50 2.50 766,246
Mar 24, 2026 2.51 2.52 2.41 2.47 2.47 498,703
Mar 23, 2026 2.57 2.63 2.41 2.47 2.47 518,582
Mar 20, 2026 2.55 2.63 2.50 2.51 2.51 625,007
Mar 19, 2026 2.61 2.63 2.51 2.57 2.57 956,406
Mar 18, 2026 2.82 2.82 2.63 2.64 2.64 790,273
Mar 17, 2026 2.89 2.90 2.79 2.83 2.83 474,645
Mar 16, 2026 3.04 3.12 2.86 2.87 2.87 503,483
Mar 13, 2026 3.17 3.27 2.99 3.00 3.00 656,416
Mar 12, 2026 3.33 3.33 3.11 3.14 3.14 773,286
Mar 11, 2026 3.26 3.44 3.12 3.38 3.38 1,634,083
Mar 10, 2026 3.21 3.52 3.21 3.26 3.26 1,074,846
Mar 9, 2026 3.00 3.25 2.92 3.22 3.22 1,102,228
Mar 6, 2026 2.96 3.08 2.94 3.02 3.02 1,075,983
Mar 5, 2026 3.09 3.09 2.92 3.00 3.00 821,425
Mar 4, 2026 3.04 3.19 3.03 3.05 3.05 602,116
Mar 3, 2026 3.07 3.16 2.99 3.06 3.06 520,405
Mar 2, 2026 2.85 3.27 2.76 3.20 3.20 1,981,721
Feb 27, 2026 3.50 3.60 3.45 3.49 3.49 547,374
Feb 26, 2026 3.50 3.59 3.37 3.55 3.55 388,758
Feb 25, 2026 3.44 3.52 3.37 3.46 3.46 355,770
Feb 24, 2026 3.45 3.56 3.35 3.43 3.43 836,118
Feb 23, 2026 3.37 3.50 3.33 3.45 3.45 499,666
Feb 20, 2026 3.48 3.49 3.34 3.39 3.39 721,578
Feb 19, 2026 3.55 3.60 3.36 3.48 3.48 1,492,839
Feb 18, 2026 3.50 3.65 3.41 3.59 3.59 1,347,553
Feb 17, 2026 3.35 3.63 3.24 3.54 3.54 2,287,395
Feb 13, 2026 3.30 3.35 3.14 3.20 3.20 3,731,812
Feb 12, 2026 2.95 3.46 2.89 3.25 3.25 4,408,680
Feb 11, 2026 2.93 3.02 2.77 3.00 3.00 2,170,198
Feb 10, 2026 2.44 3.10 2.41 2.99 2.99 7,948,237
Feb 9, 2026 2.11 2.50 2.08 2.39 2.39 2,039,243
Feb 6, 2026 2.02 2.16 1.98 2.12 2.12 1,115,264
Feb 5, 2026 1.98 2.04 1.92 1.96 1.96 798,349
Feb 4, 2026 2.03 2.04 1.91 2.02 2.02 810,992
Feb 3, 2026 1.97 2.06 1.95 2.04 2.04 358,583
Feb 2, 2026 1.99 2.11 1.96 1.98 1.98 510,813
Jan 30, 2026 2.01 2.04 1.95 1.99 1.99 589,627
Jan 29, 2026 2.03 2.06 1.98 2.05 2.05 605,566
Jan 28, 2026 2.14 2.18 2.02 2.04 2.04 782,037
Jan 27, 2026 2.03 2.20 2.02 2.13 2.13 771,124
Jan 26, 2026 2.06 2.09 2.00 2.04 2.04 546,252
Jan 23, 2026 2.09 2.15 2.05 2.06 2.06 783,394
Jan 22, 2026 1.95 2.18 1.92 2.10 2.10 1,347,917
Jan 21, 2026 1.90 1.96 1.85 1.95 1.95 899,792
Jan 20, 2026 2.00 2.01 1.84 1.87 1.87 1,212,051
Jan 16, 2026 2.19 2.20 2.01 2.02 2.02 1,374,711
Jan 15, 2026 2.15 2.16 2.01 2.13 2.13 5,955,453
Jan 14, 2026 2.14 2.22 2.13 2.15 2.15 622,414
Jan 13, 2026 2.24 2.26 2.08 2.14 2.14 1,087,607
Jan 12, 2026 2.27 2.28 2.06 2.22 2.22 1,440,129
Jan 9, 2026 2.36 2.57 2.21 2.22 2.22 2,158,715
Jan 8, 2026 2.20 2.41 2.11 2.33 2.33 2,956,514
Jan 7, 2026 2.08 2.54 2.05 2.29 2.29 13,549,728
Jan 6, 2026 1.68 2.03 1.50 1.82 1.82 5,526,626
Jan 5, 2026 1.84 1.86 1.63 1.64 1.64 3,717,383
Jan 2, 2026 1.81 1.82 1.57 1.66 1.66 1,982,822
Dec 31, 2025 1.76 1.81 1.76 1.79 1.79 756,612
Dec 30, 2025 1.80 1.81 1.76 1.77 1.77 776,933
Dec 29, 2025 1.75 1.81 1.73 1.78 1.78 675,839
Dec 26, 2025 1.85 1.85 1.74 1.78 1.78 535,484
Dec 24, 2025 1.75 1.86 1.74 1.81 1.81 693,530
Dec 23, 2025 1.86 1.93 1.69 1.75 1.75 1,640,997
Dec 22, 2025 1.77 1.85 1.77 1.81 1.81 1,102,316
Dec 19, 2025 1.74 1.78 1.71 1.75 1.75 1,267,162
Dec 18, 2025 1.73 1.77 1.68 1.72 1.72 794,034
Dec 17, 2025 1.85 1.89 1.75 1.77 1.77 884,177
Dec 16, 2025 1.95 1.96 1.83 1.85 1.85 861,342
Dec 15, 2025 2.07 2.07 1.92 1.96 1.96 766,243
Dec 12, 2025 2.08 2.12 1.97 2.09 2.09 618,387
Dec 11, 2025 2.09 2.12 2.06 2.07 2.07 476,899
Dec 10, 2025 2.07 2.15 2.05 2.09 2.09 636,587
Dec 9, 2025 2.21 2.22 2.05 2.08 2.08 746,606
Dec 8, 2025 2.22 2.25 2.16 2.19 2.19 670,039
Dec 5, 2025 2.27 2.30 2.21 2.22 2.22 472,791
Dec 4, 2025 2.24 2.36 2.22 2.27 2.27 1,061,013
Dec 3, 2025 2.25 2.29 2.13 2.27 2.27 1,432,089
Dec 2, 2025 2.44 2.45 2.20 2.23 2.23 1,741,060
Dec 1, 2025 2.53 2.59 2.35 2.42 2.42 2,312,141
Nov 28, 2025 2.31 2.34 2.23 2.24 2.24 420,675
Nov 26, 2025 2.23 2.33 2.23 2.29 2.29 732,928
Nov 25, 2025 2.16 2.25 2.13 2.25 2.25 1,649,959
Nov 24, 2025 2.32 2.33 2.10 2.16 2.16 1,634,757
Nov 21, 2025 2.35 2.42 2.28 2.33 2.33 679,907
Nov 20, 2025 2.59 2.67 2.34 2.36 2.36 1,200,110
Nov 19, 2025 2.71 2.78 2.48 2.54 2.54 1,007,217
Nov 18, 2025 2.57 2.70 2.57 2.66 2.66 793,237
Nov 17, 2025 2.62 2.79 2.55 2.59 2.59 706,898
Nov 14, 2025 2.61 2.79 2.58 2.65 2.65 811,932
Nov 13, 2025 2.83 2.95 2.67 2.69 2.69 1,216,983
Nov 12, 2025 2.75 3.00 2.75 2.86 2.86 1,131,158
Nov 11, 2025 2.81 2.84 2.62 2.75 2.75 998,108
Nov 10, 2025 2.56 2.92 2.55 2.81 2.81 1,769,050
Nov 7, 2025 2.50 2.63 2.40 2.56 2.56 1,214,668
Nov 6, 2025 2.39 2.75 2.35 2.58 2.58 2,275,047
Nov 5, 2025 2.79 2.88 2.62 2.62 2.62 1,652,650
Nov 4, 2025 2.91 2.96 2.72 2.79 2.79 2,304,122
Nov 3, 2025 3.03 3.06 2.82 3.01 3.01 1,824,718
Oct 31, 2025 3.00 3.25 2.82 3.02 3.02 4,581,769
Oct 30, 2025 2.75 3.04 2.67 2.93 2.93 7,494,385
Oct 29, 2025 2.60 2.69 2.40 2.50 2.50 4,153,081
Oct 28, 2025 2.70 2.70 2.56 2.59 2.59 1,397,251
Oct 27, 2025 2.68 2.73 2.46 2.69 2.69 10,849,043
Oct 24, 2025 2.35 2.72 2.08 2.63 2.63 5,458,132
Oct 23, 2025 1.77 2.55 1.76 2.31 2.31 19,887,439
Oct 22, 2025 1.80 1.80 1.68 1.71 1.71 386,224
Oct 21, 2025 1.81 1.85 1.75 1.80 1.80 427,431
Oct 20, 2025 1.73 1.83 1.72 1.81 1.81 296,536
Oct 17, 2025 1.76 1.80 1.73 1.73 1.73 198,210
Oct 16, 2025 1.87 1.88 1.76 1.78 1.78 423,697
Oct 15, 2025 1.81 1.90 1.79 1.84 1.84 648,141
Oct 14, 2025 1.85 1.85 1.74 1.80 1.80 584,087
Oct 13, 2025 1.89 1.92 1.84 1.86 1.86 336,626
Oct 10, 2025 1.95 1.98 1.82 1.89 1.89 1,031,492
Oct 9, 2025 1.94 2.02 1.88 1.95 1.95 521,235
Oct 8, 2025 1.87 1.95 1.84 1.94 1.94 465,986
Oct 7, 2025 1.90 1.94 1.84 1.86 1.86 494,414
Oct 6, 2025 1.83 1.90 1.80 1.89 1.89 356,986
Oct 3, 2025 1.80 1.93 1.76 1.83 1.83 713,411
Oct 2, 2025 1.79 1.84 1.70 1.78 1.78 528,174
Oct 1, 2025 1.81 1.89 1.74 1.78 1.78 627,139
Sep 30, 2025 1.78 1.83 1.73 1.82 1.82 313,304
Sep 29, 2025 1.75 1.82 1.71 1.76 1.76 417,180
Sep 26, 2025 1.70 1.76 1.67 1.74 1.74 270,098
Sep 25, 2025 1.79 1.81 1.67 1.70 1.70 368,648
Sep 24, 2025 1.96 1.96 1.80 1.83 1.83 564,166
Sep 23, 2025 1.75 1.91 1.74 1.91 1.91 821,508

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Neumora Therapeutics, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at NMRA, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation